Blue Owl Capital Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)
Blue Owl Capital Inc. Class A Common Stock OWL | 8.47 8.73 | +0.24% +3.07% Post |
Analysts' ratings for Blue Owl Capital (NYSE:OWL) over the last quarter vary from bullish to bearish, as provided by 12 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 5 | 5 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 3 | 2 | 0 | 0 |
| 2M Ago | 1 | 2 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $16.96, a high estimate of $24.00, and a low estimate of $10.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 13.34%.
Investigating Analyst Ratings: An Elaborate Study
A clear picture of Blue Owl Capital's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Brian Bedell | Deutsche Bank | Lowers | Hold | $10.00 | $15.00 |
| Michael Brown | UBS | Lowers | Neutral | $12.00 | $16.50 |
| Alexander Blostein | Goldman Sachs | Lowers | Neutral | $14.00 | $16.25 |
| Chris Kotowski | Oppenheimer | Lowers | Outperform | $24.00 | $27.00 |
| Crispin Love | Piper Sandler | Lowers | Overweight | $15.00 | $21.00 |
| Benjamin Budish | Barclays | Lowers | Overweight | $15.00 | $18.00 |
| Glenn Schorr | Evercore ISI Group | Lowers | Outperform | $17.00 | $19.00 |
| Bill Katz | TD Cowen | Lowers | Buy | $24.00 | $26.00 |
| Michael Brown | UBS | Lowers | Neutral | $16.50 | $18.00 |
| Benjamin Budish | Barclays | Lowers | Overweight | $18.00 | $19.00 |
| Michael Brown | UBS | Announces | Neutral | $18.00 | - |
| Wilma Burdis | Raymond James | Announces | Strong Buy | $20.00 | - |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Blue Owl Capital. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Blue Owl Capital compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Blue Owl Capital's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Blue Owl Capital's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Blue Owl Capital analyst ratings.
All You Need to Know About Blue Owl Capital
Blue Owl Capital Inc is one of the world's key alternative-asset managers with over $307 billion in assets under management, specializing in providing capital solutions to middle-market companies, private equity firms, and real estate owners. The firm operates three primary platforms: Credit, GP Strategic Capital, and Real Assets, offering direct lending, minority stake acquisitions in asset managers, and net lease real estate solutions. The firm operates through more than 20 offices in the Americas, and the EMEA and Asia-Pacific regions.
Blue Owl Capital's Financial Performance
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Blue Owl Capital's remarkable performance in 3M is evident. As of 30 September, 2025, the company achieved an impressive revenue growth rate of 21.15%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 0.87%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Blue Owl Capital's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.27%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Blue Owl Capital's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.05%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.65, Blue Owl Capital faces challenges in effectively managing its debt levels, indicating potential financial strain.
Understanding the Relevance of Analyst Ratings
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.